Abstract
Sleep-disordered breathing (mainly obstructive sleep apnea [OSA]) and COPD are among the most common pulmonary diseases, so a great number of patients have both disorders; this “overlap syndrome” causes more severe nocturnal hypoxemia than either disease alone. This common combination of OSA and COPD has important implications for diagnosis, treatment, and outcome. Specifically, patients with COPD and OSA have a substantially greater risk of morbidity and mortality, compared to those with either COPD or OSA alone. Only now are the interactions between these 2 systemic diseases being determined and appreciated. Many questions remain, however, with regard to disease definition, prognosis, and optimal treatment. Treatment currently consists of continuous positive airway pressure, and oxygen as needed. Noninvasive ventilation may be helpful in overlap syndrome patients, but this has not yet been well studied.
- obstructive sleep apnea
- chronic obstructive pulmonary disease
- COPD
- overlap syndrome
- nocturnal oxygen desaturation
- hypercapnic COPD
Footnotes
- Correspondence: Robert L Owens, Sleep Disorders Research Program, Brigham and Women's Hospital, 221 Longwood Avenue, Boston MA 02115. E-mail: rowens{at}partners.org.
Dr Owens presented a version of this paper at the 45th Respiratory Care Journal Conference, “Sleep Disorders: Diagnosis and Treatment,” held December 10-12, 2009, in San Antonio, Texas.
Dr Owens has disclosed no conflicts of interest. Dr. Malhotra has disclosed relationships with Philips, Pfizer, Merck, Apnex, Itamar, Sepracor, Cephalon, Sleep Group Solutions, Sleep HealthCenters, Medtronic, and Ethicon.
↵* David J Pierson MD FAARC, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Harborview Medical Center, University of Washington, Seattle, Washington.
- Copyright © 2010 by Daedalus Enterprises Inc.